ARTICLE | Clinical News
Briviact brivaracetam regulatory update
December 7, 2015 8:00 AM UTC
EMA’s CHMP recommended approval of Briviact brivaracetam from UCB to treat partial-onset seizures in epileptics ages >=16. Briviact is a high affinity synaptic vesicle protein (SV2A) ligand. ...